Reports Q1 revenue $11.15B, consensus $10.81B. The company said, “Our first quarter results reflect our team’s disciplined approach to medical cost management in an improving rate environment. Our 2025 earnings and growth profiles are solid, and we remain confident in our ability to achieve our 13% to 15% long-term adjusted EPS growth target.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH: